LGD-4033 (Ligandrol):Benefits And Boundaries: A Risk-Reward Calculus

Oct 30, 2025 Leave a message

●Tissue Selectivity: 10:1 anabolic-to-androgenic ratio, surpassing testosterone's 1:1 profile.

●Oral Efficacy: No injections required, with stable plasma concentrations over 24 hours.

●Muscle Memory Preservation: Upregulates MyoD expression, enhancing rebound growth post-cycle.

Risks and Controversies

●HPTA Suppression: Doses ≥5 mg/day suppress LH/FSH by 50–70%, necessitating post-cycle therapy (PCT).

●Lipid Dysregulation: Reduces HDL by 20% and elevates LDL by 15% in 12-week cycles.

●AR Desensitization: Chronic use (>6 months) downregulates muscle AR expression by 30%, diminishing returns.

 

Email: amyraws195@gmail.com
Whatsapp/Telegram: +852 56445864

https://www.giantrawsource.com/sarm-powder/sarms-powder-lgd4033.html

 

product-778-326

Send Inquiry

whatsapp

Phone

E-mail

Inquiry